The Alliance delivered oral comments at the July 7, 2021 HCPCS Public Meeting for Non-Drugs and Non-Biologicals to elevate concerns about the CMS preliminary coding decision to defer applications from CTP ("skin substitute") products to a subsequent coding cycle. "Both the Alliance’s clinical associations and business entity members are concerned since this delay in decision making is impacting the commercialization of these products which can be devastating to small companies. For our clinician members, the delay in getting these products to market hampers their ability to use them as one of the treatments for their patients," the Alliance stated. 

Read More